应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06609 心玮医疗-B
未开盘 11-20 16:08:27
49.580
-1.570
-3.07%
最高
50.950
最低
48.340
成交量
1.55万
今开
49.040
昨收
51.150
日振幅
5.10%
总市值
19.20亿
流通市值
15.10亿
总股本
3,873万
成交额
75.69万
换手率
0.05%
流通股本
3,046万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
心玮医疗-B:Temasek Life Sciences Private Limited减持,好仓比例降至4.95%
港股披露 · 11-20 17:41
心玮医疗-B:Temasek Life Sciences Private Limited减持,好仓比例降至4.95%
心玮医疗-B:Fullerton Management Pte Ltd减持,好仓比例降至4.95%
港股披露 · 11-20 17:24
心玮医疗-B:Fullerton Management Pte Ltd减持,好仓比例降至4.95%
心玮医疗-B:Elbrus Investments Pte. Ltd.减持,好仓比例降至4.95%
港股披露 · 11-20 17:15
心玮医疗-B:Elbrus Investments Pte. Ltd.减持,好仓比例降至4.95%
心玮医疗-B:Temasek Holdings (Private) Limited减持,好仓比例降至4.95%
港股披露 · 11-20 17:15
心玮医疗-B:Temasek Holdings (Private) Limited减持,好仓比例降至4.95%
“第十一届智通财经资本市场年会”投资者报名正式启动!
智通财经网 · 11-20 11:00
“第十一届智通财经资本市场年会”投资者报名正式启动!
心玮医疗-B回购4万股H股,涉资约202.80万港元
公告速递 · 11-19
心玮医疗-B回购4万股H股,涉资约202.80万港元
心玮医疗-B(06609.HK)11月19日斥资约202.8万港元回购4万股
智通财经 · 11-19
心玮医疗-B(06609.HK)11月19日斥资约202.8万港元回购4万股
心玮医疗-B:11月17日回购5.15万股股份,总额约270.80万港元
公告速递 · 11-17
心玮医疗-B:11月17日回购5.15万股股份,总额约270.80万港元
心玮医疗-B(06609)11月17日斥资270.8万港元回购5.15万股
智通财经 · 11-17
心玮医疗-B(06609)11月17日斥资270.8万港元回购5.15万股
心玮医疗(06609)携手思脉德医疗与爱思科技达成战略合作,共建医疗AI
智通财经 · 11-12
心玮医疗(06609)携手思脉德医疗与爱思科技达成战略合作,共建医疗AI
心玮医疗-B(06609)发布补充通告 2026年第三次临时股东会延期至11月26日
公告速递 · 11-11
心玮医疗-B(06609)发布补充通告 2026年第三次临时股东会延期至11月26日
心玮医疗-B11月10日回购1.315万股,耗资约63.89万港元
公告速递 · 11-10
心玮医疗-B11月10日回购1.315万股,耗资约63.89万港元
心玮医疗-B(06609.HK)11月10日斥资63.9万港元回购1.3万股
智通财经 · 11-10
心玮医疗-B(06609.HK)11月10日斥资63.9万港元回购1.3万股
心玮医疗-B(06609)临时股东会延期至11月26日 提名张涵任执行董事
公告速递 · 11-09
心玮医疗-B(06609)临时股东会延期至11月26日 提名张涵任执行董事
心玮医疗-B(06609)建议委任张涵为执行董事
智通财经 · 11-09
心玮医疗-B(06609)建议委任张涵为执行董事
心玮医疗-B:11月6日回购2.85万股,耗资约136.99万港元
公告速递 · 11-06
心玮医疗-B:11月6日回购2.85万股,耗资约136.99万港元
心玮医疗-B(06609)11月6日斥资约136.99万港元回购约2.85万股
智通财经 · 11-06
心玮医疗-B(06609)11月6日斥资约136.99万港元回购约2.85万股
心玮医疗-B更新10月股份变动月报表,股本维持稳定
公告速递 · 11-03
心玮医疗-B更新10月股份变动月报表,股本维持稳定
港股异动丨脑机接口多重利好催化,概念股集体走强,心玮医疗涨6%
中金财经 · 10-27
港股异动丨脑机接口多重利好催化,概念股集体走强,心玮医疗涨6%
心玮医疗-B(06609.HK)公布董事会换届安排及H股过户登记停办时间
公告速递 · 10-26
心玮医疗-B(06609.HK)公布董事会换届安排及H股过户登记停办时间
暂无数据
公司概况
公司名称:
心玮医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
上海心玮医疗科技股份有限公司是一家主要从事医疗器械研发、生产和商业化的中国公司。该公司的主要神经介入产品及在研产品包括缺血性脑卒中取栓器械,如Captor取栓器械和颅内血栓抽吸导管,颅内动脉狭窄治疗器械,如颅内球囊扩张导管及颈动脉球囊扩张导管和栓塞保护系统,出血性脑卒中治疗器械,如颅内动脉瘤栓塞辅助支架和血流导向装置,缺血性脑卒中预防器械,如左心耳封堵器,以及血管通路器械如远端通路导管、微导管、封堵球囊导管等。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06609","market":"HK","secType":"STK","nameCN":"心玮医疗-B","latestPrice":49.58,"timestamp":1795162107754,"preClose":51.15,"halted":0,"volume":15450,"delay":0,"changeRate":-0.030694037145650055,"floatShares":30460400,"shares":38729000,"eps":2.2,"marketStatus":"未开盘","change":-1.57,"latestTime":"11-20 16:08:27","open":49.04,"high":50.95,"low":48.34,"amount":756872,"amplitude":0.051026,"askPrice":50.75,"askSize":500,"bidPrice":49.58,"bidSize":50,"shortable":0,"etf":0,"ttmEps":2.84785,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":0,"adr":0,"listingDate":1629388800000,"exchange":"SEHK","adjPreClose":51.15,"openAndCloseTimeList":[[1795138200000,1795147200000],[1795150800000,1795161600000]],"volumeRatio":0.14144465806097226,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06609/tweets","defaultTab":"tweets","newsList":[{"id":"1161217745","title":"心玮医疗-B:Temasek Life Sciences Private Limited减持,好仓比例降至4.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161217745","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161217745?lang=zh_cn&edition=full","pubTime":"2026-11-20 17:41","pubTimestamp":1795167695,"startTime":"0","endTime":"0","summary":"2026年11月18日,Temasek Life Sciences Private Limited于联交所场内以每股均价51.6320港元卖出心玮医疗-B(06609)股份1.80万股,涉资约93.20万港元。属场内主动交易,即通过联交所公开市场撮合成交,属于二级市场直接买卖。该次交易后其持股量降至5%以下。Temasek Life Sciences Private Limited此次减持前持有心玮医疗-B好仓157.99万,占比5.0%;减持后持股量为156.18万,好仓比例降至4.95%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166476936","title":"心玮医疗-B:Fullerton Management Pte Ltd减持,好仓比例降至4.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166476936","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166476936?lang=zh_cn&edition=full","pubTime":"2026-11-20 17:24","pubTimestamp":1795166666,"startTime":"0","endTime":"0","summary":"2026年11月18日,Fullerton Management Pte Ltd以每股均价51.632港元减持心玮医疗-B股份1.80万股,涉资约93.20万港元,持股量降至5%以下。Fullerton Management Pte Ltd此次减持前持有心玮医疗-B好仓157.99万,占比5.0%;减持后持股量为156.18万,好仓比例降至4.95%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149122618","title":"心玮医疗-B:Elbrus Investments Pte. Ltd.减持,好仓比例降至4.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149122618","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149122618?lang=zh_cn&edition=full","pubTime":"2026-11-20 17:15","pubTimestamp":1795166152,"startTime":"0","endTime":"0","summary":"2026年11月18日,Elbrus Investments Pte. Ltd.以每股均价51.6320港元减持心玮医疗-B(06609)1.80万股,涉资约93.20万港元。Elbrus Investments Pte. Ltd.此次减持前持有心玮医疗-B好仓157.99万,占比5.0%;减持后持股量为156.18万,好仓比例降至4.95%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125645059","title":"心玮医疗-B:Temasek Holdings (Private) Limited减持,好仓比例降至4.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125645059","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125645059?lang=zh_cn&edition=full","pubTime":"2026-11-20 17:15","pubTimestamp":1795166136,"startTime":"0","endTime":"0","summary":"2026年11月18日,Temasek Holdings (Private) Limited以每股均价51.632港元减持心玮医疗-B(06609)股份1.80万股,涉资约93.20万港元;本次减持后持股比例降至5%以下。Temasek Holdings (Private) Limited此次减持前持有心玮医疗-B好仓157.99万,占比5.0%;减持后持股量为156.18万,好仓比例降至4.95%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684182978","title":"“第十一届智通财经资本市场年会”投资者报名正式启动!","url":"https://stock-news.laohu8.com/highlight/detail?id=2684182978","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684182978?lang=zh_cn&edition=full","pubTime":"2026-11-20 11:00","pubTimestamp":1795143655,"startTime":"0","endTime":"0","summary":"2026年12月8日,第十一届智通财经资本市场年会将在深圳隆重启幕。分会场二:智通财经新春策略会,活动自12月8日下午持续至12月9日全天。本次系列活动还将延伸至香港专场,2026金中环论坛暨第八届金融机构榜颁奖典礼,定于12月15日在香港举办。活动将打通深港两地资本圈层资源,打造跨地域、多层次、贯通一二级市场的专业化资本市场交流阵地。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1526093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02158","01783","07687","02420","01541","06106","02575","02659","02650","02729","02553","01021","06609","01945","09959","00305","01907","02598","06727","00699","01318","02335","09699","01951","06802","06871","09878","03681","01611","00826","01392","02392","02526","02105","02272","06821","06938","02556","02687","01866","01236","02453","03881","01396","06636","01258","00901","09877","01119","01921"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138484277","title":"心玮医疗-B回购4万股H股,涉资约202.80万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138484277","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138484277?lang=zh_cn&edition=full","pubTime":"2026-11-19 18:07","pubTimestamp":1795082823,"startTime":"0","endTime":"0","summary":"心玮医疗-B于2026年11月19日公告称,当日在香港联交所回购H股40,000股,约占回购前已发行股本的0.1311%。本次回购每股价格介乎49.10港元至51.20港元,平均每股成本为50.70港元,合计付出约202.80万港元。回购完成后,公司已发行股份为30,460,354股,库藏股总数增至1,105,450股,合计31,565,804股。公告显示,心玮医疗-B曾于2026年5月28日获股东大会批准回购授权,总额度为3,059,340股。截至本次回购完成后,公司累计已回购133,050股,占特别决议案通过当日已发行股份总数的约0.4349%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心玮医疗-B回购4万股H股,涉资约202.80万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684365927","title":"心玮医疗-B(06609.HK)11月19日斥资约202.8万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2684365927","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684365927?lang=zh_cn&edition=full","pubTime":"2026-11-19 18:00","pubTimestamp":1795082410,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","BK1100","BK1574","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121080036","title":"心玮医疗-B:11月17日回购5.15万股股份,总额约270.80万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121080036","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121080036?lang=zh_cn&edition=full","pubTime":"2026-11-17 18:50","pubTimestamp":1794912647,"startTime":"0","endTime":"0","summary":"上海心瑋醫療科技股份有限公司于2026年11月17日公告,进行了股份回购并披露了翌日披露报表。本次回购数量为5.15万股,占回购前公司已发行股本约0.1684%。每股回购价格介乎港币52.40元至52.65元,总耗资约270.80万港元。回购后,公司已发行股本由30,551,804股减少至30,500,354股,库藏股则由1,014,000股增至1,065,450股。公司同时确认,本次回购已获董事会正式授权,并符合相关上市规则及适用法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心玮医疗-B:11月17日回购5.15万股股份,总额约270.80万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684601471","title":"心玮医疗-B(06609)11月17日斥资270.8万港元回购5.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2684601471","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684601471?lang=zh_cn&edition=full","pubTime":"2026-11-17 18:49","pubTimestamp":1794912551,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心玮医疗-B(06609)发布公告,于2026年11月17日,该公司斥资270.8万港元回购5.15万股股份,每股回购价52.4-52.65港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1524520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","06609","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682537493","title":"心玮医疗(06609)携手思脉德医疗与爱思科技达成战略合作,共建医疗AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2682537493","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682537493?lang=zh_cn&edition=full","pubTime":"2026-11-12 11:39","pubTimestamp":1794454765,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,11月10日,上海心玮医疗科技股份有限公司(以下简称“心玮医疗”)携全资子公司南京思脉德医疗科技有限公司(以下简称“思脉德医疗“),与南京市爱思人工智能科技有限公司(以下简称“爱思科技“)在南京江北新区举行战略合作签约仪式。签约仪式后,MedAgnes医智方舟大模型共建项目正式启动,标志着双方合作从企业级应用探索进一步迈向医疗器械行业大模型共建与场景落地。双方以该项目为契机,围","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1522117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06609","BK1574","BK1587","150261","BK1100","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112841708","title":"心玮医疗-B(06609)发布补充通告 2026年第三次临时股东会延期至11月26日","url":"https://stock-news.laohu8.com/highlight/detail?id=1112841708","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112841708?lang=zh_cn&edition=full","pubTime":"2026-11-11 22:20","pubTimestamp":1794406850,"startTime":"0","endTime":"0","summary":"5-6. 重选陈少雄、选举鲁旭波为非执行董事,年薪各人民币12万元。其余议程与原通告一致,此次补充通告同步提供修订代表委任表格供股东使用。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198882239","title":"心玮医疗-B11月10日回购1.315万股,耗资约63.89万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198882239","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198882239?lang=zh_cn&edition=full","pubTime":"2026-11-10 19:55","pubTimestamp":1794311755,"startTime":"0","endTime":"0","summary":"心玮医疗-B于2026年11月10日发布公告,披露当日于香港联合交易所场内回购股份事宜。公告显示,公司当日回购1.315万股,占回购前已发行股份的0.043%,最高回购价为每股49.16港元,最低回购价为每股47.22港元,合计耗资约63.89万港元。本次回购完成后,公司已发行股份总数维持在31,565,804股,其中不包括库藏股份的已发行股份为30,551,804股,库藏股份则增至1,014,000股。公司进一步确认,本次交易已按照香港联合交易所有限公司证券上市规则及相关法律法规合规进行。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心玮医疗-B11月10日回购1.315万股,耗资约63.89万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682394507","title":"心玮医疗-B(06609.HK)11月10日斥资63.9万港元回购1.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2682394507","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682394507?lang=zh_cn&edition=full","pubTime":"2026-11-10 19:54","pubTimestamp":1794311645,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06609","BK1574","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107036161","title":"心玮医疗-B(06609)临时股东会延期至11月26日 提名张涵任执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1107036161","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107036161?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:25","pubTimestamp":1794234340,"startTime":"0","endTime":"0","summary":"非执行董事陈刚因工作安排将于延期后的临时股东会上退任,不再寻求连任。公司高级副总裁、COO兼CFO张涵被提名为执行董事及战略委成员,任期三年,待股东批准。临时股东会由11月13日顺延至11月26日举行;H股过户登记暂停期调整为11月23日至26日。1) 撤回原第4号普通决议案。2) 新增普通决议案:选举张涵为第三届董事会执行董事。4) H股股东如拟出席会议,须于11月20日16:30前将过户文件送达香港中央证券登记有限公司办理登记。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682890273","title":"心玮医疗-B(06609)建议委任张涵为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2682890273","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682890273?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:25","pubTimestamp":1794234313,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心玮医疗-B 发布公告,陈刚先生已知会本公司,因彼之其他工作安排,其拟于即将举行之临时股东会上退任本公司非执行董事,且不会寻求重选为非执行董事。于接获陈刚先生退任董事会职务的通知后,于2026年11月9日,董事会建议委任本公司高级副总裁、首席运营官、首席财务官、董事会秘书兼联席公司秘书张涵先生为执行董事及董事会战略委员会成员。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1587","BK1100","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128625449","title":"心玮医疗-B:11月6日回购2.85万股,耗资约136.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128625449","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128625449?lang=zh_cn&edition=full","pubTime":"2026-11-06 21:11","pubTimestamp":1793970689,"startTime":"0","endTime":"0","summary":"2026年11月6日,上海心瑋醫療科技股份有限公司公告显示,公司于当日在香港联交所回购H股股份2.85万股,占交易前已发行股本约0.093%。此次回购的每股价格介乎45.76港元至49.20港元之间,合计耗资约136.99万港元。该回购根据公司于2026年5月28日通过的购回授权进行,授权可回购股份总数为3,059,340股,截至目前已回购28,450股。公司同时确认,本次交易遵守了香港联交所证券上市规则及相关法律规定。本公告由公司董事王国辉签署,于2026年11月6日发布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心玮医疗-B:11月6日回购2.85万股,耗资约136.99万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681869021","title":"心玮医疗-B(06609)11月6日斥资约136.99万港元回购约2.85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681869021","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681869021?lang=zh_cn&edition=full","pubTime":"2026-11-06 21:08","pubTimestamp":1793970481,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心玮医疗-B(06609)发布公告,于2026年11月6日该公司斥资约136.99万港元回购约2.85万股,回购价格为每股45.76至49.2港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1519984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1587","BK1100","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192808739","title":"心玮医疗-B更新10月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1192808739","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192808739?lang=zh_cn&edition=full","pubTime":"2026-11-03 19:05","pubTimestamp":1793703943,"startTime":"0","endTime":"0","summary":"心玮医疗-B于2026年11月3日披露截至2026年10月31日的股份变动月报表。报告期内,公司注册股本总额为人民币39,834,408元,包含H股31,565,804股以及非上市股8,268,604股,面值均为每股人民币1元。本月公司已发行及库存股份数未发生新增发行、购回、注销或库藏股变动。根据月报,H股期末已发行股份共计30,593,404股,另有库存股972,400股,总数维持在31,565,804股;非上市股则维持在8,268,604股,未出现增减。截至10月末,公司股本结构保持稳定。公告由公司董事王国辉签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678149117","title":"港股异动丨脑机接口多重利好催化,概念股集体走强,心玮医疗涨6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678149117","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678149117?lang=zh_cn&edition=full","pubTime":"2026-10-27 10:50","pubTimestamp":1793069406,"startTime":"0","endTime":"0","summary":"港股脑机接口概念股集体上涨,其中,心玮医疗涨6%领衔,脑动极光涨近5%,联想集团涨超4%,南京熊猫电子跟涨。\n\n 消息面上,近期脑机接口行业受多重利好推动,我国牵头制定的《信息技术脑机接口参考架构》国际标准正式发布;工信部等七部门发文推动脑机接口产业创新发展,此外,马斯克旗下Neuralink的“大规模生产”表态亦对板块形成过刺激。\n\n 心玮医疗今日的上涨,除了板块情绪带动外,也有自身逻辑支撑。该公司计划于2026年下半年向上交所提交A股科创板上市申请,拟募集资金约5亿元,用于脑科学医疗器械建设等项目。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202610/27/20261027274498.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202610/27/20261027274498.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261027/32408660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4585","06609","MNTL","BK1574","BK4588","BK1100","VXUS","KCAI","IBRN","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161210046","title":"心玮医疗-B(06609.HK)公布董事会换届安排及H股过户登记停办时间","url":"https://stock-news.laohu8.com/highlight/detail?id=1161210046","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161210046?lang=zh_cn&edition=full","pubTime":"2026-10-26 16:36","pubTimestamp":1793003780,"startTime":"0","endTime":"0","summary":"上海心瑋醫療科技股份有限公司10月26日公告称,公司第二届董事会任期将于2026年11月届满。同日召开的董事会会议决议:拟于2026年11月13日召开2026年第三次临时股东会,审议重选并委任第三届董事会成员事宜。第三届董事会将设九名董事,任期自临时股东会批准之日起三年,具体提名如下:。为确定有资格出席并投票的H股股东名册,公司将于2026年11月10日至11月13日暂停办理H股股份过户登记。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.strokemedical.com","stockEarnings":[{"period":"1week","weight":-0.0316},{"period":"1month","weight":-0.0628},{"period":"3month","weight":-0.0068},{"period":"6month","weight":0.0522},{"period":"1year","weight":0.0685},{"period":"ytd","weight":-0.0767}],"compareEarnings":[{"period":"1week","weight":-0.0519},{"period":"1month","weight":-0.0525},{"period":"3month","weight":-0.1384},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.1326},{"period":"ytd","weight":-0.1256}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海心玮医疗科技股份有限公司是一家主要从事医疗器械研发、生产和商业化的中国公司。该公司的主要神经介入产品及在研产品包括缺血性脑卒中取栓器械,如Captor取栓器械和颅内血栓抽吸导管,颅内动脉狭窄治疗器械,如颅内球囊扩张导管及颈动脉球囊扩张导管和栓塞保护系统,出血性脑卒中治疗器械,如颅内动脉瘤栓塞辅助支架和血流导向装置,缺血性脑卒中预防器械,如左心耳封堵器,以及血管通路器械如远端通路导管、微导管、封堵球囊导管等。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.1064},{"month":2,"riseRate":0.4,"avgChangeRate":-0.067342},{"month":3,"riseRate":0.4,"avgChangeRate":-0.0145},{"month":4,"riseRate":0.4,"avgChangeRate":-0.01346},{"month":5,"riseRate":0.2,"avgChangeRate":-0.061255},{"month":6,"riseRate":0.4,"avgChangeRate":0.043804},{"month":7,"riseRate":0.6,"avgChangeRate":0.087081},{"month":8,"riseRate":0.6,"avgChangeRate":-0.042946},{"month":9,"riseRate":0.666667,"avgChangeRate":0.062043},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.049887},{"month":11,"riseRate":0.333333,"avgChangeRate":0.036576},{"month":12,"riseRate":0.8,"avgChangeRate":0.076512}],"exchange":"SEHK","name":"心玮医疗-B","nameEN":"HEARTCARE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心玮医疗-B,06609,心玮医疗-B股票,心玮医疗-B股票老虎,心玮医疗-B股票老虎国际,心玮医疗-B行情,心玮医疗-B股票行情,心玮医疗-B股价,心玮医疗-B股市,心玮医疗-B股票价格,心玮医疗-B股票交易,心玮医疗-B股票购买,心玮医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}